Author Archives

On Twitter, Muddy Waters says it’s short iQIYI (NASDAQ:IQ), believing that the company ”fraudulently and materially overstates its users, revenues, acquisition consideration, and value of its ’barter’ content.” Muddy helped Wolfpack Research prepare its own short report, which estimates that IQ inflated its 2019 revenue by 27-44% and its user numbers by 42-60%. IQ shares […]

AAXN or as we knew it before as TASR has reemergence as a great stock because of orders of Body Cameras, however is the Company Digital Ally’s who has been damaged and just had their patents upheld for the 5th time July 10, 2018. What’s the game plan?

Recent Author Comments

On What's "The 20X Weight Loss Drug?" Looking into Lashmet's New Teaser Pitch for Stansberry Venture Technology

That's what the company has been saying in presentations and filings all along, their focus is clearly on genetic disorders and predispositions and they have not done "general obesity" testing for at least several years with setmelanotide (and it was not n[...]

Go to Comment »
On "Secret is Out" -- Small Tech Stock Builds the "Eyes" Behind Self-Driving Vehicles

Thanks for your , as usual, balanced answer. It seems that he is not into stock research himself (he is more involved in his various vacations around the world) but uses is name to recommend other people’s “research”. I find this kind of sad becaus[...]

Go to Comment »
On What's Jeff Brown teasing in his "Timed Stocks Summit?"

Hi Akyula, I'm inspired by your success, interested in your discoveries too. Thank you chilubamulenga@hotmail.com[...]

Go to Comment »
On What's Jeff Brown teasing in his "Timed Stocks Summit?"

Hi Lio, would appreciate information about early stage trader. thank you chilubamulenga@hotmail.com[...]

Go to Comment »
On Microblog: Next Gen Supercycle

Hi Margo. I would appreciate it if you could send me the list also. Kind regards Tom[...]

Go to Comment »
On What's "The 20X Weight Loss Drug?" Looking into Lashmet's New Teaser Pitch for Stansberry Venture Technology

I would not own this stock at any level now that the CEO has confirmed that the drug cannot be used for the general public for obesity, but rather only for the tiny market approval that they have applied for. The CEO said, and their presentation material,[...]

Go to Comment »
On Microblog: Paul Mampilly's 100x deal

Okay, all eyes should be on NNDM today, which has had two big days in a row. Not 1005% sure that this is about, but it relates to Natron and its battery development, and somehow NNDM is an investor in that. I am also looking for new on their employment of [...]

Go to Comment »
On Shaw's "Two Gold Billionaires are investing heavily in a small $3 junior gold mining stock" Pitch

I am thinking about getting the Motley Fool subscription, but they have several subscription options, which one did you get?, thank you.[...]

Go to Comment »
On Microblog: John Engel Editor, Stansberry Innovations Report September 2019...U.S. Gov't Could Soon Replace Social Security Cards with “ID Coin” This hack-proof technology could be 20x bigger than Bitcoin, Ethereum and Ripple COMBINED. With expected market growth of 80,782% – this is likely your LAST chance to make a fortune from crypto technology.

Alice, Could you contact me? RICHERDIAMONDS@GMAIL.COM[...]

Go to Comment »
On Microblog: Stansberry's Next China Growth Portfolio

The first one sounds like #SE, already pitched by others.[...]

Go to Comment »
On "Secret is Out" -- Small Tech Stock Builds the "Eyes" Behind Self-Driving Vehicles

Where does the Microvision (MVIS ) Automotive 3D Lidar sensor fit into the potential[...]

Go to Comment »
On "Secret is Out" -- Small Tech Stock Builds the "Eyes" Behind Self-Driving Vehicles

Luminar is LAGR[...]

Go to Comment »
On "Secret is Out" -- Small Tech Stock Builds the "Eyes" Behind Self-Driving Vehicles

Any newsletter teases for Microvision (MVSN) in relation to Autonomous Vehicle technology? It's a very small cap stock ($1.90 or so) that is allegedly going to be sold to a bigger player in need of it's technology. Thanks.[...]

Go to Comment »
On Microblog: Stansberry's Next China Growth Portfolio

Haven’t gotten to that one yet, but I’ll try to have a look. Thanks for the reminder![...]

Go to Comment »
On "Pre-IPO Secrets" from Ian Wyatt -- Palantir and the "Next Tesla"

Well, sometimes those patterns do repeat... a huge collapse for SuRo today as Palantir finally completed its Direct listing and began trading. PLTR looks like it rose on the day, but that’s just because the entry “benchmark” price was $7.50, not th[...]

Go to Comment »
On Shaw's "Two Gold Billionaires are investing heavily in a small $3 junior gold mining stock" Pitch

Why would that help? The dollar is not backed by gold, neither literally nor even symbolically at this point. If there’s a new Bretton Woods agreement that fixes currencies to gold, which seems laughably unlikely for political reasons, I’m sure they [...]

Go to Comment »
On Microblog: Stansberry's Next China Growth Portfolio

I posted that same question yesterday or Tuesday. They had the initial pitch came out a week ago and the polished pitch by Brian Tycangco a supposed specialist in China markets and Asian markets. It definitely caught my interest. I've been really researc[...]

Go to Comment »
On Shaw's "Two Gold Billionaires are investing heavily in a small $3 junior gold mining stock" Pitch

World base price of gold may be raised to off-set debt of countries, including the USA???!!![...]

Go to Comment »
On Elliott Wave Trader

I have been a member of Elliottwavetrader.net for 4 years. I can say without a doubt it has helped my trading tremendously. It is the only thing I have seen that helps me make sense of the market. It is simply amazing how the market respects the wave pa[...]

Go to Comment »
On Microblog: Lou Basenese - Does anyone know which stock he is talking about?

Yes, it's Definately Resonant. Its true and any day will be the day ..i found the patent that matches the one Lou has in his tease. Checkout Resn co bio. Board members match...its them.[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info